VEQTA is in active development — Request your early access conversation.
Pharmaceutical EBITDA Intelligence

Your Commercial, Supply Chain,
and Financial Signals —
Unified Into One Layer. So the Right People Act in Time.

VEQTA unifies commercial market data, ERP supply chain signals, and gross-to-net financials into one intelligence layer — so pharma leaders act on what matters, when it matters.

Request Early Access Explore the Platform
veqta.ai / intelligence / portfolio-overview
Portfolio Intelligence · Q4 2026 · All Molecules
$4.2M
EBITDA at Risk
WOS 2.1
Supply Exposure
MAPE 31%
Forecast Miss
+$1.8M
GTN Normalized
Biosimilar erosion — Molecule A — Northeast — ↓18% unit share
−$2.1M
2m ago
Weeks of Supply critical — Molecule D — Midwest — WOS 2.1
Flag
8m ago
GTN leakage normalized — Molecule G — Portfolio — On Target
+$1.8M
14m ago
Biosimilar erosion — Molecule A — Northeast — ↓18% share — EBITDA flagged
WOS critical — Molecule D — Midwest — reorder threshold breached
GTN leakage normalized — Portfolio — margin trajectory stable
Forecast miss — Molecule C — Southeast — MAPE 31% — variance explained
GTN bridge diverging — Molecule F — Q3 at risk
Scenario complete — Channel mix shift — EBITDA uplift +$2.1M modeled
Market access barrier — Molecule K — Formulary exclusion detected
Portfolio ranking updated — 12 molecules scored by revenue exposure
Biosimilar erosion — Molecule A — Northeast — ↓18% share — EBITDA flagged
WOS critical — Molecule D — Midwest — reorder threshold breached
GTN leakage normalized — Portfolio — margin trajectory stable
Forecast miss — Molecule C — Southeast — MAPE 31% — variance explained
GTN bridge diverging — Molecule F — Q3 at risk
Scenario complete — Channel mix shift — EBITDA uplift +$2.1M modeled
Market access barrier — Molecule K — Formulary exclusion detected
Portfolio ranking updated — 12 molecules scored by revenue exposure
The Problem

Your data exists. Your P&L doesn't benefit from it.

Commercial, supply chain, and finance teams each operate from different systems — and no one connects a market signal to its EBITDA consequence until the quarter is already lost.

Talk to Us
01
Three data worlds, zero integration
Commercial market data, ERP supply chain signals, and gross-to-net financials live in separate platforms. Nobody automatically connects a market shift to its margin consequence.
02
Reporting tells you what happened
Standard dashboards describe the past. They don't explain why a variance occurred, what it means for this quarter's number, or what action to take.
03
Signal volume without priority
Analysts surface dozens of variances per cycle. CFOs need to know which three are financially material — ranked by dollar impact, not by data source or analyst judgment.
04
GTN leakage caught in hindsight
Gross-to-net erosion from rebates, chargebacks, and access barriers is almost always identified after quarter close — never in-flight, when something can still be done.
05
Inventory risk invisible to finance
Supply chain tracks weeks-of-supply. Finance tracks revenue. Neither sees the other's data in real time. The cost of that gap shows up as write-offs, lost sales, and expedite charges.
The Platform

Automated, explainable intelligence — for every signal that matters.

↓18%
Unit Share
High
Risk Level
−$2.1M
EBITDA Impact
Biosimilar Erosion — Molecule A — Northeast
Q1 2026Q4 2026
Commercial Signal Detection
Continuously monitors third-party market data across your entire portfolio. Biosimilar erosion, competitive entry, and formulary changes are flagged the moment they cross materiality thresholds — with their EBITDA impact calculated automatically.
WOS 2.1
Weeks of Supply
8 SKUs
At Risk
Alert
Status
Supply Risk — Molecule D — Midwest Region
Critical (2.1 WOS)Safe (≥8 WOS)
Inventory Risk Monitoring
Connected to your ERP and supply chain data, VEQTA monitors weeks-of-supply at the product and region level. Risks surface before they become operational failures — integrated with commercial demand signals for full context.
MAPE 31%
Forecast Error
−$1.4M
vs Plan
Explained
Variance
GTN Bridge — Molecule C — Southeast
Variance driven by channel mix shift (–$0.8M) and formulary exclusion (–$0.6M) — both flagged 6 weeks prior.
GTN & Variance Explanation
Every forecast miss is automatically explained in plain language — with the root cause, contributing factors, and financial impact broken out. GTN bridge movements tracked in-flight so leakage is caught before quarter close.
+$2.1M
Modeled Uplift
3 Scenarios
Simulated
High
Confidence
Scenario: Channel Mix Rebalancing — Portfolio Wide
Current State+$2.1M EBITDA
Scenario Simulation
Model the EBITDA consequences of decisions before they are made. Channel mix shifts, pricing interventions, supply rebalancing — each simulated against real portfolio actuals so leaders commit with confidence.
The Intelligence Engine

Four layers that work together — not in sequence.

Most platforms give you one layer: reporting. VEQTA runs four layers simultaneously — so every signal is detected, translated into dollars, and connected to a decision — in real time.

Unified Data Layer
Commercial, supply chain, and financial data normalized into a single model — across molecules, regions, and time.
Signal Detection Layer
Five signal families monitored continuously. Ranked by financial materiality — not data source or analyst discretion.
Financial Translation Layer
Every signal expressed as a dollar amount. GTN bridge modeling, margin impact scoring, and forecast reconciliation — real time.
Decision Intelligence Layer
Scenario simulation and predictive signals surface before thresholds are breached — so leaders act, not react.
VEQTA AI ENGINE Commercial Signals Supply Chain Financial GTN Scenario Engine Pharma Biosimilars Med Devices Specialty Rx Generics
Why VEQTA

Built for pharma leaders accountable for the number.

Unlike generic BI tools or siloed reporting platforms, VEQTA is purpose-built for the financial and commercial complexity of pharmaceutical portfolios.

In-Flight, Not After-the-Fact
VEQTA surfaces signals during the quarter — not in the month-end deck. Leaders have time to act, not just explain what went wrong.
Real-time signal detection vs monthly reporting cycles
Every Signal Priced in Dollars
A biosimilar erosion signal is only useful if it comes with an EBITDA number attached. VEQTA translates every market event into margin impact automatically.
Financial translation built into the detection layer
Three Data Sources, One View
Commercial market data, ERP supply chain signals, and gross-to-net financials — unified into a single intelligence model. No more cross-referencing spreadsheets across three systems.
SAP, market data, and GTN financials connected
Product Tiers

Two products. One platform.

VEQTA Signal
Signal
Intelligence detection and financial translation — for teams that need to know what's happening and what it costs, in real time.
  • Unified commercial, supply chain, and financial data view
  • Continuous signal monitoring across your portfolio
  • Automatic EBITDA impact quantification per signal
  • GTN bridge and gross-to-net variance tracking
  • Weeks-of-supply risk monitoring with demand integration
  • Role-specific views: CFO, Commercial, Supply Chain, Finance
VEQTA Intelligence
Intelligence
Everything in Signal, plus forward-looking simulation and AI-generated decision narratives — for leaders who need to act ahead of the curve.
  • Everything in VEQTA Signal
  • Scenario simulation — model EBITDA consequences before deciding
  • Predictive signals — early warning before thresholds are breached
  • AI-generated variance narratives in plain language
  • Portfolio ranking by financial exposure and signal severity
  • Conversational intelligence layer for ad-hoc analysis
Who It's For

Built for the four roles accountable for the number.

CFO
See EBITDA exposure before the quarter closes.
Real-time margin visibility across the portfolio. Know which signals carry dollar risk — and how large — without waiting for the month-end deck.
EBITDA ImpactGTN BridgeMargin Risk
Commercial Leadership
Act on market signals before competitors do.
Continuous monitoring of demand trends, biosimilar erosion, and formulary changes — tied directly to revenue impact by molecule and region.
Market SignalsBiosimilar RiskDemand Trends
Supply Chain
Prevent stockouts and write-offs before they cost you.
In-flight inventory risk detection at the product and region level — integrated with commercial demand signals so supply decisions are tied to market reality.
Weeks of SupplyInventory RiskERP Connected
Finance Manager
Reconcile forecast to actual without the manual lift.
Automated forecast-vs-actual variance analysis with plain-language explanations. Know the why behind every miss — with root causes identified, not just numbers flagged.
Variance AnalysisMAPE / WAPEForecast Bridge
Frequently Asked Questions

Answers to the questions pharma leaders ask us first.

VEQTA is built for pharmaceutical commercial and finance leaders — CFOs, VP Commercial, Supply Chain directors, and Finance Managers — who are accountable for portfolio EBITDA performance and need real-time intelligence to act, not just report.
VEQTA is designed to integrate with three core data environments: third-party commercial market data (such as IQVIA), ERP and supply chain systems (including SAP), and gross-to-net financial feeds. The integration architecture is discussed under NDA during early access conversations.
BI tools describe the past. VEQTA detects signals in real time, translates them into EBITDA impact automatically, and surfaces them ranked by financial materiality — not by data source. It's the difference between a rearview mirror and a heads-up display.
Every early access conversation starts with an NDA. We then run a structured discovery session to understand your portfolio, data environment, and key decision pain points — and show you a live POC demo scoped to your context. No sales deck. No generic demo.
Early Access

Request an early access conversation.

VEQTA is in active development. We're engaging a select group of pharma organizations ahead of launch. All conversations are NDA-protected from the first exchange.

NDA-protected conversations. No sales deck. No spam.